Emerging pharmacologic treatment options for fragile X syndrome
Tori L Schaefer, Matthew H Davenport, Craig A Erickson Division of Child and Adolescent Psychiatry, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA Abstract: Fragile X syndrome (FXS) is the most common single gene cause of intellectual disability and autism spectrum disor...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-04-01
|
| Series: | The Application of Clinical Genetics |
| Online Access: | http://www.dovepress.com/emerging-pharmacologic-treatment-options-for-fragile-x-syndrome-peer-reviewed-article-TACG |